ABSI · Absci Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-30 | Szela Mary T |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Open market purchase of shares in accordance with Issuer's trading policies. |
Common Stock
|
12,900 |
| 2026-06-24 | McClain Sean |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of 150,000 performance-based RSUs upon achievement of a closing stock price equal to or exceeding $10.00 per share, as previously reported in the Reporting Person's Form 4 filed on March 21, 2024, and does not represent a discretionary trade by the Reporting Person. |
Common Stock
|
59,896 |
| 2026-06-04 | Sirosh Joseph |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Common Stock
|
10,100 |
| 2026-06-04 | Rabinovitsj Daniel A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Stock Option (right to buy)
|
39,800 |
| 2026-06-04 | Szela Mary T |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Common Stock
|
8,400 |
| 2026-06-04 | VAN HOUTEN FRANS |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Common Stock
|
10,100 |
| 2026-06-04 | Sirosh Joseph |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Stock Option (right to buy)
|
39,800 |
| 2026-06-04 | Szela Mary T |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Stock Option (right to buy)
|
33,200 |
| 2026-06-04 | VAN HOUTEN FRANS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Stock Option (right to buy)
|
39,800 |
| 2026-06-04 | MCGINNIS KAREN K |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Stock Option (right to buy)
|
39,800 |
| 2026-06-04 | Pangalos Menelas N |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Stock Option (right to buy)
|
39,800 |
| 2026-06-04 | MCGINNIS KAREN K |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Common Stock
|
10,100 |
| 2026-06-04 | Pangalos Menelas N |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Common Stock
|
10,100 |
| 2026-06-04 | Rabinovitsj Daniel A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Common Stock
|
10,100 |
| 2026-05-31 | Jonasson Zachariah |
CFO / CBO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
8,319 |
| 2026-05-13 | Pangalos Menelas N |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Open market purchase of shares in accordance with Issuer's trading policies. |
Common Stock
|
37,453 |
| 2026-03-12 | Busch Andreas |
Chief Scientific Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open market purchase of shares in accordance with Issuer's trading policies. |
Common Stock
|
100,000 |
| 2026-03-03 | Busch Andreas |
Chief Scientific Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
1,257 |
| 2026-03-03 | Bedrick Todd |
SVP, CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
5,282 |
| 2026-03-03 | Walker Shelby J. |
See Remarks |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
9,825 |
| 2026-03-03 | Jonasson Zachariah |
CFO / CBO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
10,848 |
| 2026-03-03 | McClain Sean |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
25,316 |
| 2026-03-02 | Pangalos Menelas N |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan in connection with service as a member of the scientific advisory board. The RSUs shall vest and be settled in full over a one year period beginning January 1, 2026, in substantially equal monthly installments, subject to the Reporting Person's continuous service through each vesting date. |
Common Stock
|
5,800 |
| 2026-03-02 | Walker Shelby J. |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Common Stock
|
90,300 |
| 2026-03-02 | Jonasson Zachariah |
CFO / CBO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
8,307 |
| 2026-03-02 | Bedrick Todd |
SVP, CAO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Stock Option (right to buy)
|
195,900 |
| 2026-03-02 | McClain Sean |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Common Stock
|
406,200 |
| 2026-03-02 | Pangalos Menelas N |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option issued in connection with service as a member of the scientific advisory board shall vest and become exercisable over a one year period beginning January 1, 2026, in substantially equal monthly installments, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (right to buy)
|
22,800 |
| 2026-03-02 | McClain Sean |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Stock Option (right to buy)
|
1,603,200 |
| 2026-03-02 | Jonasson Zachariah |
CFO / CBO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Stock Option (right to buy)
|
534,400 |
| 2026-03-02 | Bedrick Todd |
SVP, CAO |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Common Stock
|
49,600 |
| 2026-03-02 | Jonasson Zachariah |
CFO / CBO |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Common Stock
|
135,400 |
| 2026-03-02 | Walker Shelby J. |
See Remarks |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Stock Option (right to buy)
|
356,300 |
| 2026-02-27 | Pangalos Menelas N |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Open market purchase of shares in accordance with Issuer's trading policies. |
Common Stock
|
75,095 |
| 2026-02-23 | McClain Sean |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
On February 23, 2026, the Reporting Person exercised options to purchase 396,399 shares of the Issuer's Common Stock at an exercise price of $1.21 per share prior to their March 3, 2026 expiration. Shares were withheld to cover the exercise price and applicable tax withholding obligations. |
Stock Option (right to buy)
|
396,399 |
| 2026-02-23 | McClain Sean |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
On February 23, 2026, the Reporting Person exercised options to purchase 396,399 shares of the Issuer's Common Stock at an exercise price of $1.21 per share prior to their March 3, 2026 expiration. Shares were withheld to cover the exercise price and applicable tax withholding obligations. |
Common Stock
|
267,008 |
| 2026-02-23 | McClain Sean |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
On February 23, 2026, the Reporting Person exercised options to purchase 396,399 shares of the Issuer's Common Stock at an exercise price of $1.21 per share prior to their March 3, 2026 expiration. Shares were withheld to cover the exercise price and applicable tax withholding obligations. |
Common Stock
|
396,399 |
| 2026-02-03 | Busch Andreas |
Chief Scientific Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
1,469 |
| 2026-02-02 | Jonasson Zachariah |
CFO / CBO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
17,496 |
| 2026-02-02 | McClain Sean |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
26,761 |
| 2026-02-02 | Bedrick Todd |
SVP, CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
3,659 |
| 2026-01-28 | Bedrick Todd |
SVP, CAO |
Award↑
Filing footnotes — Common Stock (Direct)
The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on January 10, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Common Stock
|
15,000 |
| 2026-01-28 | Bedrick Todd |
SVP, CAO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on January 10, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Stock Option (right to buy)
|
59,400 |
| 2025-12-05 | VAN HOUTEN FRANS |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Open market purchase of shares in accordance with Issuer's trading policies. |
Common Stock
|
40,000 |
| 2025-11-30 | Jonasson Zachariah |
CFO / CBO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares of withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
8,320 |
| 2025-10-14 | Busch Andreas |
Chief Scientific Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
3,092 |
| 2025-10-14 | Bedrick Todd |
SVP, CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
21,950 |
| 2025-10-14 | McClain Sean |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
23,293 |
| 2025-10-14 | Jonasson Zachariah |
CFO / CBO |
Tax↓
Filing footnotes — Common Stock (Direct)
Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person. |
Common Stock
|
387 |
| 2025-09-22 | Bedrick Todd |
SVP, CAO |
Buy↑
Filing footnotes — Common Stock (Direct)
Open market purchase of shares in accordance with Issuer's trading policies. |
Common Stock
|
10,000 |